Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.76
-0.46 (-0.20%)
AAPL  277.69
-1.16 (-0.42%)
AMD  217.29
-0.24 (-0.11%)
BAC  53.58
-0.07 (-0.14%)
GOOG  316.97
-3.15 (-0.98%)
META  639.75
-8.20 (-1.27%)
MSFT  486.88
-5.13 (-1.04%)
NVDA  179.44
+2.44 (1.38%)
ORCL  201.28
-0.67 (-0.33%)
TSLA  427.29
-2.88 (-0.67%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.